why choose us

First received: August 08, 2023

Clinical Trial: Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Follicular Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma

Brief Summary: The goal of this study is to learn about the safety and effectiveness of the combination of tazemetostat pills in combination with mosunetuzumab injections for people with follicular lymphoma who haven't received treatment before.The investigators hypothesize that tazemetostat with mosunetuzumab has the potential to increase the efficacy of the product without compromising the safety.Tazemetostat is a drug that inhibits EZH2, an enzyme known to drive the development of B-cell lymphomas, and inhibiting it…

Read more